ATI RN
Safety Pharmacology Across the Lifespan ATI Quizlet Questions
Question 1 of 5
Which of the following antipsychotic drugs has high affinity for D2 and 5-HT 2 receptors?
Correct Answer: D
Rationale: In this question, the correct answer is D) Risperidone. Risperidone is known for having high affinity for both D2 and 5-HT 2 receptors, making it an effective antipsychotic medication. Clozapine (option B) is incorrect because while it is an effective antipsychotic, it is not specifically known for its high affinity for both D2 and 5-HT 2 receptors. Thiothixene (option C) primarily acts on D2 receptors but does not have the same dual receptor affinity as risperidone. Droperidol (option A) primarily acts on D2 receptors but is not commonly used as an antipsychotic medication. Educationally, understanding the receptor profiles of antipsychotic medications is crucial for selecting the most appropriate drug for a patient based on their symptoms and potential side effects. Knowing the specific receptor affinities can help healthcare providers make informed decisions when prescribing medications for patients with psychiatric disorders.
Question 2 of 5
Which of the following features do MAO inhibitors and tricyclic antidepressants have in common?
Correct Answer: C
Rationale: The correct answer is C) Increase levels of biogenic amines. MAO inhibitors and tricyclic antidepressants both work by inhibiting the reuptake of neurotransmitters such as serotonin, norepinephrine, and dopamine. By blocking the action of monoamine oxidase (MAO) or inhibiting the reuptake of these neurotransmitters, both types of medications lead to an increase in the levels of biogenic amines in the synaptic cleft, ultimately enhancing neurotransmission and improving mood in individuals with depression. Option A) Act postsynaptically to produce their effect is incorrect because MAO inhibitors and tricyclic antidepressants primarily act presynaptically by altering neurotransmitter levels in the synaptic cleft. Option B) Can precipitate hypotensive crises if certain foods are ingested is incorrect because this statement is more specific to MAO inhibitors due to the potential interaction with foods rich in tyramine, leading to hypertensive crises, not hypotensive crises. Option D) Are useful for the manic phase of bipolar disorder is incorrect because while tricyclic antidepressants can sometimes be used in bipolar disorder, they are not considered first-line treatments for the manic phase. Antidepressants can potentially induce manic episodes in individuals with bipolar disorder, so they are generally used cautiously and in combination with mood stabilizers. Understanding the similarities and differences between MAO inhibitors and tricyclic antidepressants is crucial for healthcare professionals, especially when prescribing these medications to patients. It is essential to understand their mechanisms of action, potential side effects, drug interactions, and appropriate clinical uses to ensure safe and effective pharmacological treatment for individuals across the lifespan.
Question 3 of 5
Indicate the antidepressant agent, which is a phenyltolylpropylamine derivative:
Correct Answer: C
Rationale: The correct answer is C) Fluoxetine. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and belongs to the phenyltolylpropylamine class of antidepressants. It works by increasing the levels of serotonin in the brain, which helps regulate mood and emotions. A) Paroxetine is also an SSRI, but it is not a phenyltolylpropylamine derivative. Paroxetine belongs to the chemical class of aryloxypropanamines. B) Maprotiline is a tetracyclic antidepressant and does not belong to the phenyltolylpropylamine class. D) Amitriptyline is a tricyclic antidepressant and is not a phenyltolylpropylamine derivative. Understanding the classification of antidepressants is crucial in pharmacology to differentiate their mechanisms of action, potential side effects, and indications for use. Knowing the specific characteristics of each class of antidepressants helps healthcare professionals make informed decisions when prescribing medications for patients with depression. This knowledge is vital for ensuring patient safety and optimizing treatment outcomes.
Question 4 of 5
Which of the following benzodiazepines is less likely to cause cumulative and residual effects with multiple doses?
Correct Answer: C
Rationale: In the context of safety pharmacology across the lifespan, understanding the pharmacokinetics and pharmacodynamics of benzodiazepines is crucial for safe medication administration. In this scenario, the correct answer is C) Lorazepam. Lorazepam has a shorter half-life compared to other benzodiazepines listed, which makes it less likely to cause cumulative and residual effects with multiple doses. Its shorter duration of action reduces the risk of drug accumulation in the body, making it a safer choice for individuals who may require repeated dosing. Analyzing the other options: A) Clorazepate: Clorazepate has active metabolites that can accumulate and lead to prolonged sedation and effects with repeated doses. B) Quazepam: Quazepam is a long-acting benzodiazepine, increasing the likelihood of cumulative effects with multiple doses. D) Prazepam: Prazepam has a long half-life and active metabolites, which can result in cumulative effects and prolonged sedation upon repeated dosing. Educationally, this question highlights the importance of selecting benzodiazepines with appropriate pharmacokinetic profiles to minimize the risk of cumulative and residual effects in patients. Understanding these differences can help healthcare professionals make informed decisions when prescribing medications, especially in vulnerable populations where drug accumulation can have serious consequences.
Question 5 of 5
Which of the following sedative-hypnotic drugs does not potentiate the CNS depressant effects of ethanol, phenothiazines, or tricyclic antidepressants?
Correct Answer: A
Rationale: In the context of safety pharmacology across the lifespan, understanding the interactions between different drugs is crucial to ensure safe medication practices. In this question, the correct answer is A) Buspirone. Buspirone is a unique anxiolytic medication that does not potentiate the CNS depressant effects of ethanol, phenothiazines, or tricyclic antidepressants. Buspirone acts by binding to serotonin and dopamine receptors, unlike other sedative-hypnotic drugs like phenobarbital, diazepam, and chloral hydrate. Phenobarbital, a barbiturate, enhances CNS depression when combined with other depressant drugs like ethanol or tricyclic antidepressants. Diazepam, a benzodiazepine, and chloral hydrate, a sedative-hypnotic, both potentiate the effects of CNS depressants, leading to increased sedation and respiratory depression. For learners studying safety pharmacology, it is essential to grasp the specific mechanisms of action of different drugs to predict potential drug interactions accurately. Understanding which drugs potentiate CNS depression helps healthcare professionals make informed decisions when prescribing medications, especially in vulnerable populations such as children or the elderly, where drug interactions can have severe consequences. By selecting the correct answer, learners demonstrate their grasp of safe prescribing practices and their ability to consider the unique pharmacological properties of each drug in clinical scenarios.